2022

1. Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer

   Cancers, Vol. 14, Núm. 16

2. Clinical landscape of LAG-3-targeted therapy

   Immuno-Oncology and Technology, Vol. 14